282 related articles for article (PubMed ID: 7035955)
1. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.
Mahony L; Carnero V; Brett C; Heymann MA; Clyman RI
N Engl J Med; 1982 Mar; 306(9):506-10. PubMed ID: 7035955
[TBL] [Abstract][Full Text] [Related]
2. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.
Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E
Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
Supapannachart S; Khowsathit P; Patchakapati B
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
[TBL] [Abstract][Full Text] [Related]
5. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
6. Surgical closure of patent ductus arteriosus in 268 preterm infants.
Wagner HR; Ellison RC; Zierler S; Lang P; Purohit DM; Behrendt D; Waldhausen JA
J Thorac Cardiovasc Surg; 1984 Jun; 87(6):870-5. PubMed ID: 6374300
[TBL] [Abstract][Full Text] [Related]
7. [Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants].
Vogtmann C; Grubbe G; Ruckhäberle KE; Böttcher H; Ockert C
Monatsschr Kinderheilkd; 1988 Sep; 136(9):636-9. PubMed ID: 3070369
[TBL] [Abstract][Full Text] [Related]
8. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
Itabashi K; Ohno T; Nishida H
J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of patent ductus arteriosus in preterm infants].
Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
[TBL] [Abstract][Full Text] [Related]
12. [Indomethacin and persistent ductus arterious in the pre-term newborn infant with respiratory insufficiency].
Hurtado del Río D; Holden Barker AM; Segura MA; Lozano González C
Arch Inst Cardiol Mex; 1981; 51(1):83-8. PubMed ID: 7212861
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin therapy on the first day of life in infants with very low birth weight.
Mahony L; Caldwell RL; Girod DA; Hurwitz RA; Jansen RD; Lemons JA; Schreiner RL
J Pediatr; 1985 May; 106(5):801-5. PubMed ID: 3998921
[TBL] [Abstract][Full Text] [Related]
14. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
[No Abstract] [Full Text] [Related]
15. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
[TBL] [Abstract][Full Text] [Related]
17. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
Cordero L; Nankervis CA; Gardner D; Giannone PJ
J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
[TBL] [Abstract][Full Text] [Related]
18. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants.
Lai TH; Soong WJ; Hwang B
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(1):17-23. PubMed ID: 2278224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
